Descriptor English: | Complement Factor H | ||||||
Descriptor Spanish: |
Factor H de Complemento
| ||||||
Descriptor Portuguese: | Fator H do Complemento | ||||||
Descriptor French: | Facteur H du complément | ||||||
Entry term(s): |
Factor H Factor H, Complement |
||||||
Tree number(s): |
D12.776.124.486.274.920.325.200 D12.776.124.790.223.200 D12.776.377.715.182.200 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D017242 | ||||||
Scope note: | An important soluble regulator of the alternative pathway of complement activation (COMPLEMENT ACTIVATION PATHWAY, ALTERNATIVE). It is a 139-kDa glycoprotein expressed by the liver and secreted into the blood. It binds to COMPLEMENT C3B and makes iC3b (inactivated complement 3b) susceptible to cleavage by COMPLEMENT FACTOR I. Complement factor H also inhibits the association of C3b with COMPLEMENT FACTOR B to form the C3bB proenzyme, and promotes the dissociation of Bb from the C3bBb complex (COMPLEMENT C3 CONVERTASE, ALTERNATIVE PATHWAY). |
||||||
Allowable Qualifiers: |
AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
Pharm Action: |
Complement Inactivating Agents |
||||||
Registry Number: | 80295-65-4 | ||||||
CAS Type 1 Name: | Complement factor H | ||||||
Previous Indexing: |
Beta Globulins (1978-1979) Complement 3b Inactivators (1980-1992) Glycoproteins (1978-1979) |
||||||
Public MeSH Note: | 93; COMPLEMENT FACTOR H was indexed under COMPLEMENT 3B INACTIVATORS 1980-92 & under BETA GLOBULINS and GLYCOPROTEINS 1978-79 |
||||||
Online Note: | use COMPLEMENT FACTOR H (NM) to search COMPLEMENT FACTOR H 1978-92 |
||||||
History Note: | 93; was COMPLEMENT FACTOR H (NM) 1978-92 |
||||||
DeCS ID: | 30775 | ||||||
Unique ID: | D017242 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1993/01/01 | ||||||
Date of Entry: | 1992/05/07 | ||||||
Revision Date: | 2005/07/07 |
-
-
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins
|
Complement Factor H
- Preferred
Concept UI |
M0026162 |
Scope note | An important soluble regulator of the alternative pathway of complement activation (COMPLEMENT ACTIVATION PATHWAY, ALTERNATIVE). It is a 139-kDa glycoprotein expressed by the liver and secreted into the blood. It binds to COMPLEMENT C3B and makes iC3b (inactivated complement 3b) susceptible to cleavage by COMPLEMENT FACTOR I. Complement factor H also inhibits the association of C3b with COMPLEMENT FACTOR B to form the C3bB proenzyme, and promotes the dissociation of Bb from the C3bBb complex (COMPLEMENT C3 CONVERTASE, ALTERNATIVE PATHWAY). |
Preferred term | Complement Factor H |
Entry term(s) |
Factor H Factor H, Complement |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey